International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases

This study is an international effort to learn more about a very rare condition called Neutral Lipid Storage Disease (NLSD) or Triglyceride Deposit Cardiomyovasculopathy (TGCV). It's so rare that doctors don't yet have enough information to fully understand how it develops or changes in people over time. Imagine trying to solve a puzzle when you only have a few pieces – this study is like bringing all those puzzle pieces together from around the world.

The main aim is to create a big picture of NLSD/TGCV by collecting information from patients everywhere. They want to find out things like when the disease typically starts, what health issues patients experience, and how the condition progresses over many years. This will help doctors understand what might make the disease better or worse, and which treatments are most effective.

Because NLSD/TGCV is so uncommon, no single country has enough patients to study it properly. By working together internationally, researchers can gather enough information to make real progress. They're setting up a special registry, which is like a secure database, to store all this important patient information. They are also including patients with a specific blood cell abnormality called Jordans' anomaly, even if their genetic cause of NLSD isn't yet known, to make sure no one is left out.